Opioid litigation is also an overhang for the three main drug distributors in the U.S.: Cardinal Health Inc., AmerisourceBergen Corp. and McKesson Corp. The companies have proposed a $10 billion settlement. That seems premature, as all of the cases haven’t been consolidated yet, Cowen analyst Charles Rhyee said. While the risk is “impossible to assess,” Rhyee said, “the distributors have strong legal defenses to test in court.”
   
This article provided by Bloomberg News.

First « 1 2 » Next